Agios Pharmaceuticals Inc. (AGIO)
NASDAQ · Healthcare
Agios Pharmaceuticals Inc. Shareholder Equity 2011–2025
Agios Pharmaceuticals Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Agios Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 1.19B, a 22.57% decrease year-over-year.
- Agios Pharmaceuticals Inc. shareholder equity for 2025 were 1.19B, a 22.57% decrease from 2024.
- Agios Pharmaceuticals Inc. shareholder equity for 2024 were 1.54B, a 90.00% increase from 2023.
- Agios Pharmaceuticals Inc. shareholder equity for 2023 were 811.0M, a 26.33% decrease from 2022.
- Agios Pharmaceuticals Inc. shareholder equity for 2022 were 1.10B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Agios Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,193 |
| 2024 | $1,541 |
| 2023 | $811 |
| 2022 | $1,101 |
| 2021 | $1,292 |
| 2020 | $400 |
| 2019 | $641 |
| 2018 | $688 |
| 2017 | $376 |
| 2016 | $359 |
| 2015 | $345 |
| 2014 | $424 |
| 2013 | $131 |
| 2012 | $-72 |
Agios Pharmaceuticals Inc. Shareholder Equity — FAQ
Agios Pharmaceuticals Inc. (AGIO) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AGIO's shareholder equity history?
The chart and table above show Agios Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.